190 results on '"Shon, K"'
Search Results
2. Seven years of preoperative BTA abdominal wall preparation and the Macquarie system for surgical management of complex ventral hernia
3. The integration of pharmacology and pathophysiology into locoregional chemotherapy delivery via mass fluid transfer
4. Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases
5. Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
6. Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
7. Seven years of preoperative BTA abdominal wall preparation and the Macquarie system for surgical management of complex ventral hernia
8. Intra-arterial Liver Isolation Chemotherapy via an Implantable Vascular Access Device to Facilitate Repeated Vascular Access for Patients with Hepatic Metastases from Colorectal Cancer (The SYS-CAPLIOX Trial)
9. Angiographic Intervention in the Diagnosis and Treatment of Acute Unstable Lower GI Haemorrhage — A Retrospective Study
10. Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
11. The ALERT model of care for the assessment and personalized management of patients with lymphoedema
12. Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial
13. Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
14. The ALERT model of care for the assessment and personalized management of patients with lymphoedema.
15. Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors.
16. Clinical Audit of Contemporary Radiation Doses in a University Hospital Coronary Computed Tomography Angiography Practice
17. The Relationship Between Extra-Coronary Calcification and Coronary Artery Lesion Characteristics
18. CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity
19. Discovery of a Covalent Inhibitor of KRASG12C(AMG 510) for the Treatment of Solid Tumors
20. Discovery of (R)‑8-(6-Methyl-4-oxo-1,4,5,6-tetrahydro-pyrrolo[3,4‑b]-pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)-amino)-quinazolin-4(3H)‑one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological...
21. Phase equilibrium in a special class of polydisperse fluid models.
22. Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors
23. New methods for calculating the dew/bubble curves of classical model fluids
24. Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
25. Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
26. Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases
27. Structure–Activity Relationships of Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Investigations of Various 6,5-Heterocycles to Improve Metabolic Stability
28. Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
29. Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
30. Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
31. CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity
32. Design, Synthesis, and Biological Evaluation of Potent c-Met Inhibitors
33. Effect of Microwave Heating on Ullmann-Type Heterocycle-Aryl Ether Synthesis Using Chloro-Heterocycles.
34. Effect of microwave heating on Ullmann-type heterocycle-aryl ether synthesis using chloro-heterocycles
35. Effects of Essential Oils Supplementation on Growth Performance, IgG Concentration and Fecal Noxious Gas Concentration of Weaned Pigs
36. The Effects of Dietary Biotite V Supplementation on Growth Performance, Nutrients Digestibility and Fecal Noxious Gas Content in Finishing Pigs
37. Effects of Lactobacillus reuteri-based Direct-fed Microbial Supplementation for Growing-Finishing Pigs
38. Investigation of an Underground Tunnel by Seismic Tomography
39. Influences of Plant Extract Supplementation on Performance and Blood Characteristics in Weaned Pigs
40. Evaluation Effects of Spray-dried Egg Protein Containing Specific Egg Yolk Antibodies as a Substitute for Spray-dried Plasma Protein or Antibiotics in Weaned Pigs
41. COHOMOLOGY VANISHING IN HILBERT SPACES
42. Mapping properties for convolutions involving hypergeometric functions
43. THE -PROBLEM FOR HOLOMORPHIC (0, 2)-FORMS ON PSEUDOCONVEX DOMAINS IN SEPARABLE HILBERT SPACES AND D.F.N. SPACES
44. Structural requirements of the epidermal growth factor receptor for tyrosine phosphorylation of eps8 and eps15, substrates lacking Src SH2 homology domains
45. A Comparative Study of Residence Time Distributions in a Kneader, Continuous Mixer, and Modular Intermeshing Co-Rotating and Counter-Rotating Twin Screw Extruders
46. SOLUTION STRUCTURE OF CONOTOXIN Y-PIIIE FROM CONUS PURPURASCENS, NMR, 14 STRUCTURES
47. Compatibility enhancement of ABS/polycarbonate blends
48. MicroO-conotoxin MrVIA inhibits mammalian sodium channels, but not through site I
49. Alterations of voltage-activated sodium current by a novel conotoxin from the venom of Conus gloriamaris
50. fd Coat Protein Structure in Membrane Environments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.